CD226hiCD8+ T Cells Are a Prerequisite for Anti-TIGIT Immunotherapy
- 1 July 2020
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Immunology Research
- Vol. 8 (7) , 912-925
Abstract
Clinical trials are evaluating the efficacy of anti-TIGIT for use as single-agent therapy or in combination with programmed death 1 (PD-1)/programmed death-ligand 1 blockade. How and whether a TIGIT blockade will synergize with immunotherapies is not clear. Here, we show that CD226loCD8+ T cells accumulate at the tumor site and have an exhausted phenotype with impaired functionality. In contrast, CD226hiCD8+ tumor-infiltrating T cells possess greater self-renewal capacity and responsiveness. Anti-TIGIT treatment selectively affects CD226hiCD8+ T cells by promoting CD226 phosphorylation at tyrosine 322. CD226 agonist antibody-mediated activation of CD226 augments the effect of TIGIT blockade on CD8+ T-cell responses. Finally, mFOLFIRINOX treatment, which increases CD226hiCD8+ T cells in patients with pancreatic ductal adenocarcinoma, potentiates the effects of TIGIT or PD-1 blockade. Our results implicate CD226 as a predictive biomarker for cancer immunotherapy and suggest that increasing numbers of CD226hiCD8+ T cells may improve responses to anti-TIGIT therapy.Keywords
All Related Versions
Funding Information
- National Research Foundation of Korea (NRF-2016M3A9E8941331, NRF-2018R1D1A1B07050715)
- Ministry for Health and Welfare, Republic of Korea (HI15C0972)
- Asan Institute for Life Sciences, Asan Medical Center (2019-763)
This publication has 50 references indexed in Scilit:
- Itch expression by Treg cells controls Th2 inflammatory responsesJournal of Clinical Investigation, 2013
- PD-1 promotes immune exhaustion by inducing antiviral T cell motility paralysisJournal of Experimental Medicine, 2013
- The TIGIT/CD226 Axis Regulates Human T Cell FunctionThe Journal of Immunology, 2012
- Decreased expression of DNAM‐1 on NK cells from acute myeloid leukemia patientsImmunology & Cell Biology, 2011
- T cell stimulator cells, an efficient and versatile cellular system to assess the role of costimulatory ligands in the activation of human T cellsJournal of Immunological Methods, 2010
- Loss of DNAM‐1 contributes to CD8+ T‐cell exhaustion in chronic HIV‐1 infectionEuropean Journal of Immunology, 2010
- The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicityProceedings of the National Academy of Sciences, 2009
- A novel molecular interaction for the adhesion of follicular CD4 T cells to follicular DCEuropean Journal of Immunology, 2009
- DNAM-1 promotes activation of cytotoxic lymphocytes by nonprofessional antigen-presenting cells and tumorsJournal of Experimental Medicine, 2008
- The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cellsNature Immunology, 2008